176 related articles for article (PubMed ID: 34952478)
1. "Subclinical atherosclerosis in acromegaly: Possible association with cardiovascular risk factors rather than disease activity".
de Almeida MCC; Freire CMV; Nunes MDCP; Soares BS; Barbosa MM; Giannetti AV; Zille GP; Miranda PAC; Ribeiro-Oliveira A; Drummond JB
Growth Horm IGF Res; 2022 Feb; 62():101442. PubMed ID: 34952478
[TBL] [Abstract][Full Text] [Related]
2. Increased arterial intima-media thickness by B-M mode echodoppler ultrasonography in acromegaly.
Colao A; Spiezia S; Cerbone G; Pivonello R; Marzullo P; Ferone D; Di Somma C; Assanti AP; Lombardi G
Clin Endocrinol (Oxf); 2001 Apr; 54(4):515-24. PubMed ID: 11318788
[TBL] [Abstract][Full Text] [Related]
3. ASSESSMENT OF DIASTOLIC DYSFUNCTION, ARTERIAL STIFFNESS, AND CAROTID INTIMA-MEDIA THICKNESS IN PATIENTS WITH ACROMEGALY.
Cansu GB; Yılmaz N; Yanıkoğlu A; Özdem S; Yıldırım AB; Süleymanlar G; Altunbaş HA
Endocr Pract; 2017 May; 23(5):536-545. PubMed ID: 28156155
[TBL] [Abstract][Full Text] [Related]
4. Low serm Fibroblast Growth Factor-21 levels is not associated with Carotid intima-media thickness in acromegaly patients.
Uygur MM; Dereli Yazıcı D; Gogas Yavuz D
J Endocrinol Invest; 2022 Jul; 45(7):1405-1412. PubMed ID: 35334074
[TBL] [Abstract][Full Text] [Related]
5. Arterial properties in acromegaly: relation to disease activity and associated cardiovascular risk factors.
Yaron M; Izkhakov E; Sack J; Azzam I; Osher E; Tordjman K; Stern N; Greenman Y
Pituitary; 2016 Jun; 19(3):322-31. PubMed ID: 26873588
[TBL] [Abstract][Full Text] [Related]
6. Endothelial dysfunction and increased carotid intima-media thickness in patients with spondyloarthritis without traditional cardiovascular risk factors.
Ben Tekaya A; Boukriba S; Fendri A; Rouached L; Saidane O; Bouden S; Tekaya R; Ben Salem K; Mahmoud I; Habiba M; Abdelmoula L
RMD Open; 2022 Jul; 8(2):. PubMed ID: 35793876
[TBL] [Abstract][Full Text] [Related]
7. Cardiovascular consequences of early-onset growth hormone excess.
Colao A; Spinelli L; Cuocolo A; Spiezia S; Pivonello R; di Somma C; Bonaduce D; Salvatore M; Lombardi G
J Clin Endocrinol Metab; 2002 Jul; 87(7):3097-104. PubMed ID: 12107207
[TBL] [Abstract][Full Text] [Related]
8. The visceral adiposity index, lipid accumulation product, and plasma atherogenic index are associated with subclinical atherosclerosis in patients with newly diagnosed acromegaly.
Özbek M; Çalapkulu M; Hepşen S; Sencar ME; Bostan H; Öztürk Ünsal İ; Çakal E
Turk J Med Sci; 2021 Oct; 51(5):2600-2606. PubMed ID: 36441155
[TBL] [Abstract][Full Text] [Related]
9. Racial and Ethnic Differences in the Association Between Classical Cardiovascular Risk Factors and Common Carotid Intima-Media Thickness: An Individual Participant Data Meta-Analysis.
Nonterah EA; Crowther NJ; Klipstein-Grobusch K; Oduro AR; Kavousi M; Agongo G; Anderson TJ; Asiki G; Boua PR; Choma SSR; Couper DJ; Engström G; de Graaf J; Kauhanen J; Lonn EM; Mathiesen EB; Micklesfield LK; Okazaki S; Polak JF; Rundek T; Salonen JT; Tollman SM; Tuomainen TP; Grobbee DE; Ramsay M; Bots ML;
J Am Heart Assoc; 2022 Aug; 11(15):e023704. PubMed ID: 35876421
[TBL] [Abstract][Full Text] [Related]
10. Effect of a six-month treatment with lanreotide on cardiovascular risk factors and arterial intima-media thickness in patients with acromegaly.
Colao A; Marzullo P; Lombardi G
Eur J Endocrinol; 2002 Mar; 146(3):303-9. PubMed ID: 11888835
[TBL] [Abstract][Full Text] [Related]
11. Cardiac mass and function, carotid artery intima-media thickness, and lipoprotein levels in growth hormone-deficient adolescents.
Lanes R; Gunczler P; Lopez E; Esaa S; Villaroel O; Revel-Chion R
J Clin Endocrinol Metab; 2001 Mar; 86(3):1061-5. PubMed ID: 11238486
[TBL] [Abstract][Full Text] [Related]
12. Visfatin Levels May be an Early Marker of Atherosclerosis in Patients with Acromegaly.
Piskinpasa H; Okuturlar Y; Dogansen SC; Akdeniz YS; Esen A; Sadri S; Pirhan O; Gemici AA; Serin SO; Gedikbası A; Adas M; Mert M
Horm Metab Res; 2019 Oct; 51(10):649-654. PubMed ID: 31487747
[TBL] [Abstract][Full Text] [Related]
13. Similar progression of carotid intima-media thickness in 7-year surveillance of patients with mild SLE and controls, but this progression is still promoted by dyslipidaemia, lower HDL levels, hypertension, history of lupus nephritis and a higher prednisolone usage in patients.
Ajeganova S; Gustafsson T; Lindberg L; Hafström I; Frostegård J
Lupus Sci Med; 2020; 7(1):e000362. PubMed ID: 32095248
[TBL] [Abstract][Full Text] [Related]
14. Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: Case control study of 281 SLE patients and 281 individually matched population controls.
Gustafsson JT; Herlitz Lindberg M; Gunnarsson I; Pettersson S; Elvin K; Öhrvik J; Larsson A; Jensen-Urstad K; Svenungsson E
PLoS One; 2017; 12(4):e0174572. PubMed ID: 28414714
[TBL] [Abstract][Full Text] [Related]
15. Is elevated urotensin II level a predictor for increased cardiovascular risk in subjects with acromegaly?
Demirpence M; Guler A; Yilmaz H; Sayin A; Pekcevik Y; Turkon H; Colak A; Ari EM; Aslanipour B; Kocabas GU; Calan M
J Endocrinol Invest; 2019 Feb; 42(2):207-215. PubMed ID: 29804270
[TBL] [Abstract][Full Text] [Related]
16. Acromegaly: Cardiovascular risk factors, cardiovascular manifestations and early vascular alterations in relation to disease activity.
Harsha MM; Tewari S; Gupta SK; Khanna R; Kumar S; Garg N; Kapoor A; Goel PK
Indian Heart J; 2021; 73(4):499-502. PubMed ID: 34474766
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular system changes in rheumatoid arthritis patients with continued low disease activity.
Biskup M; Biskup W; Majdan M; Targońska-Stępniak B
Rheumatol Int; 2018 Jul; 38(7):1207-1215. PubMed ID: 29774373
[TBL] [Abstract][Full Text] [Related]
18. Carotid intima-media thickness and serum proinflammatory cytokine levels in rosacea patients without cardiovascular risk factors.
Ertekin SS; Koku Aksu AE; Koçyiğit A; Güler EM; Baykara Ulusan M; Gürel MS
Dermatol Ther; 2021 Jan; 34(1):e14733. PubMed ID: 33389789
[TBL] [Abstract][Full Text] [Related]
19. Blood coagulation and fibrinolysis in patients with acromegaly: increased plasminogen activator inhibitor-1 (PAI-1), decreased tissue factor pathway inhibitor (TFPI), and an inverse correlation between growth hormone and TFPI.
Erem C; Nuhoglu I; Kocak M; Yilmaz M; Sipahi ST; Ucuncu O; Ersoz HO
Endocrine; 2008 Jun; 33(3):270-6. PubMed ID: 19016004
[TBL] [Abstract][Full Text] [Related]
20. IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition.
Reid TJ; Jin Z; Shen W; Reyes-Vidal CM; Fernandez JC; Bruce JN; Kostadinov J; Post KD; Freda PU
Pituitary; 2015 Dec; 18(6):808-19. PubMed ID: 25907335
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
